Kesler Norman & Wride LLC bought a new position in shares of Manhattan Associates, Inc. (NASDAQ:MANH – Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 2,060 shares of the software maker’s stock, valued at approximately $580,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Tobam bought a new position in Manhattan Associates during the first quarter worth about $25,000. Innealta Capital LLC purchased a new position in Manhattan Associates during the second quarter valued at approximately $26,000. Benjamin Edwards Inc. purchased a new position in Manhattan Associates during the first quarter valued at approximately $27,000. International Assets Investment Management LLC purchased a new position in Manhattan Associates during the second quarter valued at approximately $27,000. Finally, Contravisory Investment Management Inc. purchased a new position in Manhattan Associates during the first quarter valued at approximately $31,000. Institutional investors own 98.45% of the company’s stock.
Manhattan Associates Price Performance
Shares of Manhattan Associates stock opened at $286.28 on Wednesday. The firm has a market cap of $17.63 billion, a PE ratio of 93.56 and a beta of 1.50. Manhattan Associates, Inc. has a 1 year low of $182.97 and a 1 year high of $287.63. The company has a 50 day simple moving average of $263.30 and a two-hundred day simple moving average of $242.75.
Insider Transactions at Manhattan Associates
In other news, EVP James Stewart Gantt sold 6,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $256.50, for a total value of $1,539,000.00. Following the completion of the sale, the executive vice president now directly owns 46,287 shares in the company, valued at approximately $11,872,615.50. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.72% of the company’s stock.
Analyst Ratings Changes
Several equities analysts recently commented on the stock. DA Davidson boosted their price objective on shares of Manhattan Associates from $260.00 to $285.00 and gave the company a “buy” rating in a research note on Wednesday, July 24th. Loop Capital boosted their price objective on shares of Manhattan Associates from $265.00 to $285.00 and gave the company a “buy” rating in a research note on Monday, September 16th. StockNews.com cut shares of Manhattan Associates from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, Citigroup lifted their target price on shares of Manhattan Associates from $257.00 to $287.00 and gave the company a “neutral” rating in a research report on Wednesday, September 25th. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $264.57.
View Our Latest Stock Analysis on Manhattan Associates
Manhattan Associates Company Profile
Manhattan Associates, Inc develops, sells, deploys, services, and maintains software solutions to manage supply chains, inventory, and omni-channel operations. It offers Warehouse Management Solution for managing goods and information across the distribution centers; Manhattan Active Warehouse Management, a cloud native and version less application for the associate; and Transportation Management Solution for helping shippers navigate their way through the demands and meet customer service expectations at the lowest possible freight costs; Manhattan SCALE, a portfolio of logistics execution solution; and Manhattan Active Omni, which offers order management, store inventory and fulfillment, POS, and customer engagement tools for enterprises and stores.
Further Reading
- Five stocks we like better than Manhattan Associates
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- What Does Downgrade Mean in Investing?
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- How to Use Stock Screeners to Find Stocks
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for Manhattan Associates Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Manhattan Associates and related companies with MarketBeat.com's FREE daily email newsletter.